Next Article in Journal
A Combination of Sorafenib, an Immune Checkpoint Inhibitor, TACE and Stereotactic Body Radiation Therapy versus Sorafenib and TACE in Advanced Hepatocellular Carcinoma Accompanied by Portal Vein Tumor Thrombus
Next Article in Special Issue
Comparative Efficacy of Tapentadol versus Tapentadol Plus Duloxetine in Patients with Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Randomized Non-Inferiority Clinical Trial
Previous Article in Journal
Developing ROR1 Targeting CAR-T Cells against Solid Tumors in Preclinical Studies
 
 
Article

Article Versions Notes

Cancers 2022, 14(15), 3617; https://doi.org/10.3390/cancers14153617
Action Date Notes Link
article pdf uploaded. 25 July 2022 15:31 CEST Version of Record https://www.mdpi.com/2072-6694/14/15/3617/pdf-vor
article pdf uploaded. 25 July 2022 15:39 CEST Updated version of record https://www.mdpi.com/2072-6694/14/15/3617/pdf-vor
article xml file uploaded 26 July 2022 06:05 CEST Original file -
article xml uploaded. 26 July 2022 06:05 CEST Update https://www.mdpi.com/2072-6694/14/15/3617/xml
article pdf uploaded. 26 July 2022 06:05 CEST Updated version of record https://www.mdpi.com/2072-6694/14/15/3617/pdf
article supplementary file uploaded. 26 July 2022 06:05 CEST - https://www.mdpi.com/2072-6694/14/15/3617#supplementary
article html file updated 26 July 2022 06:06 CEST Original file -
article html file updated 13 August 2022 03:38 CEST Update https://www.mdpi.com/2072-6694/14/15/3617/html
Back to TopTop